University Medical Center Schleswig-Holstein, Campus Kiel

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)	Insulin Resistance, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, metabolic disease, prediabetes syndrome	Recruiting	Phase 2	2026-09-16		NCT07286747
D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab	Embolism and Thrombosis, cardiovascular disorder, thrombotic disease, vascular disorder	Not yet recruiting	Not stated	2026-07-22		NCT07684066

Clinical trials